# Glycopyrrolate

NDC: 66794-204
Generic name: Glycopyrrolate
Labeler / Manufacturer: Piramal Critical Care Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20190711

FDA application: ANDA210842

## Active ingredients

- GLYCOPYRROLATE: .2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66794-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66794-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=83d70378-011b-4ce3-e053-2991aa0a22be